Crossmark

The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network

Crossref DOI link: https://doi.org/10.1007/s00277-018-3397-3

Published Online: 2018-06-21

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ricchi, Paolo

Meloni, Antonella

Pistoia, Laura

Spasiano, Anna

Spiga, Alessandra

Allò, Massimo

Gamberini, Maria Rita

Lisi, Roberto

Campisi, Saveria

Peluso, Angelo

Missere, Massimiliano

Renne, Stefania

Mangione, Maurizio

Positano, Vincenzo

Pepe, Alessia
Funding

Funding for this research was provided by:

The MIOT project receives “no-profit support” from industrial sponsorships (Chiesi Farmaceutici S.p.A. and ApoPharma Inc.).
License Information

Text and Data Mining valid from 2018-06-21
More Information

Article History

Received: 12 April 2018

Accepted: 12 June 2018

First Online: 21 June 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below